The Dow Jones Sustainability Indexes are developed through collaboration between S&P Dow Jones Indices of the United States and Robeco SAM, a Swiss research specialist in the area of socially responsible investment. This year Sysmex has been selected for inclusion in the DJSI World for the second consecutive year.
Creating a System for Operating Mobile Pharmacies as a Disaster Response Measure – Sysmex Corporation, the Hyogo Pharmaceutical Society and Shinkai Transport Systems, Ltd. announce the signing of an agreement to cooperate on disaster relief activities, aimed at operating mobile pharmacies in times of disaster.
In order to continue supporting the initiatives of the GHIT Fund, which aims to assist in the application of Japanese technological innovation to healthcare in developing countries, we will be extending our provision of donations for a five-year period from 2018. By participating in the GHIT Fund, we will move forward with initiatives to develop […]
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has opened a new R&D facility within its Kawasaki INnovation Gateway at SKYFRONT in the city of Kawasaki, Kanagawa Prefecture, to pursue R&D in bioinformatics, a key technology toward the realization of personalized medicine.
Sysmex Corporation has reached an agreement with Oxford Gene Technology IP Limited (“OGT”) to acquire all shares in OGT. Through this move, Sysmex aims to obtain OGT’s business and expertise in the cytogenetics1 domain and its reagent development capabilities used in next-generation sequencers (NGSs)2, thereby reinforcing its base in the life science business.
Sysmex Corporation has received the Invention Award in the National Commendation for Invention1, sponsored by the Japan Institute of Invention and Innovation, for its hematology analyzers that enables the rapid evaluation of the effects of administering iron preparations. The award ceremony is scheduled to be held in Tokyo on Monday, June 12.
Sysmex Corporation has received the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Prize for Science and Technology (Development Category), for its Development of White Blood Cell Five-Part Differentiation and an Atypical White Blood Cell Differentiation Method.
Sysmex Corporation announces the establishment of a new company, Sysmex Harmony Co., Ltd., to promote the employment of people with disabilities.
Sysmex Corporation and the University of Tokyo have entered into a research collaboration agreement involving the development of a target gene panel. The objective is to analyze lung cancer, sarcoma and other specified types of diseases, and analyze genetic mutations related to rare diseases with a view to the clinical application of genomic medicine.
Sysmex Corporation announced today that it has signed an agreement with the National Health Laboratory (NHL), a Myanmar government institution, to conduct scientific support activities with the aim of enhancing the quality of clinical testing in the country.